BIO Protocol is a decentralized science (DeSci) management and liquidity protocol, with the token $BIO on ERC-20.
Currently, it is a project on Binance Launchpool, and it will be listed on Binance on January 3, 2025.
$BIO, as a project in the DeSci field, is an innovative emerging field with great growth potential. It is like bringing scientific research into the Web3 world, allowing scientists, patients, and the general public to participate in research, addressing issues faced by traditional science, such as difficulty in financing, lack of data transparency, and so on.
BIO Protocol has undergone multiple rounds of financing, with its valuation continuously increasing. BIO has established partnerships with several important entities, including Pfizer Ventures and research laboratories from top universities. These partners will enhance the feasibility of the project and community support, also showing market recognition of the project.
The token economic model of BIO is reasonably designed, including token distribution, reward mechanisms, and network governance. The distribution is also quite reasonable, with allocations for the team, advisors, private investors, public sales, ecosystem incentives, etc., ensuring that all parties have the motivation to contribute to the ecosystem. (Details can be found in the project white paper.)
https://docs.bio.xyz/bio
The circulation situation of $BIO:
$BIO has a total supply of 3.32 billion, with an initial circulation of 1.296 billion. Binance Launchpool accounts for 3%, the team for 21.20%, advisors for 4.70%, private investors for 13.60%, community auctions and public investors for 20%, community airdrops for 6%, ecosystem incentives for 19%, and liquidity and marketing for 2.50%.
At the time of listing on Binance, approximately 39.05% of the BIO tokens will be in circulation, while the remaining tokens may be released in the future according to the needs of the project or adjusted through governance mechanisms.
BIO brings new financing and commercialization pathways to the biotechnology field through innovative DeSci and its token economic model, with significant development potential worthy of ongoing attention.